Eli Lilly Opens Early Access to Next-Gen Weight-Loss Drug Retatrutide
Eli Lilly Grants Early Access to Revolutionary Weight-Loss Drug Retatrutide On August 3, 2026, pharmaceutical titan Eli Lilly announced an early access program for its experimental obesity drug, Retatrutide. This…
